Scheriproct Ointment in Kenya

SCHERIPROCT OINTMENT comes in a single tube. Its active ingredients are Prednisolone Caproate 1.3mg and Cinchocaine Hydrochloride 1mg (per gram of ointment, though exact strength varies slightly by region, e.g., 1.9mg prednisolone hexanoate and 5.0mg cinchocaine hydrochloride per gram in some formulations). Scheriproct ointment, and its suppository form, are widely used in Kenya to treat pain, itching, and discomfort associated with irritated anorectal tissues. These conditions include haemorrhoids (piles), proctitis (inflammation of the rectum), pruritus ani (anal itching), milder forms of anal fissures (small tears), and for post-operative pain relief in the anal area. While generally available without a prescription in Kenya, its usage MUST align with a physician’s guidance due to the presence of a corticosteroid.

Unpacking the Formulation: Key Components and Their Mechanism

Scheriproct Ointment’s effectiveness stems from its dual-action formula, combining an anti-inflammatory corticosteroid with a local anesthetic.

• Prednisolone Caproate (1.3mg/g or 1.9mg/g):
  • Class: Corticosteroid (medium-potency).
  • Mechanism of Action: Prednisolone is a potent anti-inflammatory agent. When applied topically, it reduces the body’s inflammatory response in the affected tissues. This action decreases swelling, redness, and heat, which are characteristic signs of inflammation. In the context of haemorrhoids and other anorectal conditions, it significantly alleviates the inflammation and swelling that cause pain and discomfort.
• Cinchocaine Hydrochloride (1mg/g or 5mg/g):
  • Class: Local Anesthetic.
  • Mechanism of Action: Cinchocaine works by reversibly blocking nerve impulses in the local area of application. It specifically inhibits the initiation and conduction of pain signals along nerve fibers. This results in a numbing effect, providing rapid relief from pain, itching, burning, and soreness associated with irritated anorectal tissues. Its fast action provides immediate comfort.

The combination of these two ingredients offers comprehensive relief: the corticosteroid addresses the underlying inflammation and swelling, while the local anesthetic provides quick symptomatic relief from pain and itching.

Addressing Health Concerns and User Needs

Scheriproct Ointment directly addresses the common and often debilitating symptoms associated with anorectal conditions, significantly improving patient comfort.

• Rapid Pain Relief: Cinchocaine quickly numbs the affected area, providing fast relief from pain and burning sensations.
• Reduced Itching and Discomfort: The combined action effectively alleviates intense itching (pruritus) and general discomfort.
• Anti-Inflammatory Action: Prednisolone reduces the swelling and inflammation of haemorrhoids and other irritated tissues.
• Comprehensive Symptom Control: It targets multiple symptoms simultaneously, offering more complete relief than single-ingredient products.
• Supports Healing: By reducing inflammation and discomfort, it creates a more conducive environment for the body’s natural healing processes.

Identifying Indications for Use

SCHERIPROCT OINTMENT is intended for the short-term treatment of symptoms arising from irritated anorectal tissues. Its indications include:

• Haemorrhoids (Piles): Both internal and external, particularly when inflamed, painful, or itchy.
• Proctitis: Inflammation of the lining of the rectum.
• Pruritus ani: Persistent itching around the anus.
• Milder forms of Anal Fissures: Small tears in the lining of the anus, providing symptomatic relief (though deeper fissures may require other treatments).
• Postoperative Pain Relief: To manage pain and discomfort after anal or rectal surgery.

Primary Uses

The primary uses of SCHERIPROCT OINTMENT include:

• Relieving pain, swelling, and itching associated with haemorrhoids.
• Reducing inflammation in conditions like proctitis.
• Providing symptomatic comfort for anal itching and mild fissures.
• Managing post-surgical discomfort in the anorectal area.

Understanding Potential Side Effects and Critical Precautions

While Scheriproct Ointment provides effective relief, users must be aware of potential side effects, particularly with prolonged use, and adhere to critical precautions.

Common Side Effects (Generally mild and at the application site)

• Temporary burning or stinging sensation upon application (usually mild and subsides quickly).
• Allergic skin reactions (rare, but possible).
• Skin thinning (atrophy) with prolonged use.
• Skin discoloration (rare).

Less Common but More Serious Side Effects (Requiring Medical Attention)

• Systemic Absorption: Although applied topically, prolonged or excessive use of corticosteroids can lead to systemic absorption, potentially causing side effects similar to oral steroids (e.g., adrenal suppression, especially in children, or Cushing’s syndrome-like symptoms). This is rare with short-term, recommended use.
• Worsening of Infections: Corticosteroids can mask or worsen existing infections (viral, bacterial, fungal). If the area being treated has an infection, it should be treated concurrently with an appropriate antimicrobial.
• Allergic Reactions: Severe allergic reactions (e.g., swelling of the face, lips, tongue, difficulty breathing, widespread rash) are rare but require immediate medical attention.

Critical Safety Warnings and Precautions for SCHERIPROCT OINTMENT

While available without a prescription in Kenya, Scheriproct Ointment contains a corticosteroid. Therefore, its usage MUST be in accordance with a physician’s guidance, and strict adherence to dosage and duration limits is essential.

Contraindications and High-Risk Patients

• Hypersensitivity: Do not use if allergic to prednisolone caproate, cinchocaine hydrochloride, other local anesthetics, or any other ingredients in the ointment.
• Infections: Do not use if there is a viral infection (e.g., herpes, shingles, chicken-pox) in the treated area. Also, do not use if there are untreated bacterial or fungal infections of the skin or elsewhere. Any infection in the area must be treated simultaneously with an appropriate anti-infective.
• Tuberculosis or Syphilis: Do not use if these conditions are present in the area to be treated.
• Pregnancy: Contraindicated during the first trimester of pregnancy due to potential risks to fetal development. Use in later trimesters only if the benefit outweighs the risk and under strict medical supervision.
• Breastfeeding: Use with caution and only if advised by a doctor, as small amounts of corticosteroids may pass into breast milk.
• Long-Term Use: Avoid prolonged continuous use (generally not more than 5-7 days). Extended use increases the risk of skin thinning, systemic absorption, and rebound symptoms upon discontinuation.
• Children: Long-term continuous therapy with topical corticosteroids in infants and small children should be avoided due to the risk of adrenal suppression.
• Latex Products: Ingredients in Scheriproct ointment (e.g., castor oil) may reduce the effectiveness of latex products like condoms. If used in the same area, this could compromise contraception or protection against STIs. Consider alternative forms of contraception if this is a concern.

Administration and Monitoring

• For External/Rectal Use ONLY: Do not ingest.
• Hygiene: Gently but thoroughly wash and dry the anal area before applying the ointment. Best applied after a bowel movement.
• Do Not Use Waterproof Dressings: Do not cover the treated area with waterproof dressings, as this can increase systemic absorption of the corticosteroid.
• Eyes: Avoid contact with eyes. If contact occurs, rinse thoroughly with water.
• Worsening Symptoms: If symptoms worsen, or do not improve after 7 days of treatment, discontinue use and consult a doctor. Persistent symptoms or bleeding require prompt medical evaluation to rule out more serious conditions.
• New Symptoms: Report any new or unusual symptoms to your doctor.

Drug Interactions

• Ritonavir, Cobicistat (HIV Medications): Co-treatment with these medications can increase the risk of systemic corticosteroid side effects. Close monitoring by a doctor is advised.
• Other Topical Steroids: Avoid using other topical corticosteroid products in the same area without medical advice.

Recommended Dosage and Administration Guidelines

The dosage and administration of SCHERIPROCT OINTMENT should always follow the physician’s guidance or the instructions on the product packaging.

• For External Application (around the anus):
  1. Gently but thoroughly wash and dry the anal area.
  2. Squeeze a small quantity (about the size of a pea) of ointment onto your fingertip.
  3. Spread it gently over the skin around the anus and just inside the anal opening. Do not rub it in vigorously.
• For Internal Application (inside the anus):
  1. Screw the separate applicator (nozzle) completely onto the tube.
  2. Squeeze the tube until the applicator is full of ointment (this is typically one dose).
  3. Carefully insert the applicator entirely into the anus.
  4. While gently squeezing the tube, withdraw the applicator.
• Frequency: Generally, apply the ointment twice a day. For quicker initial relief in severe discomfort, it may be applied three or four times on the first day, then reduced to twice daily.
• Duration of Treatment: Use only for a short-term period, usually 5 to 7 days. Do not use for more than 7 days without consulting a doctor due to the risk of side effects from the corticosteroid.
• After Each Use: After each internal use, clean the applicator thoroughly with a paper towel to remove residue, then rinse it under warm water for about 1 minute, and dry it with a paper towel.

Price in Kenya (Approximate)

As of Friday, July 4, 2025, at 10:49:46 AM EAT, the approximate price for SCHERIPROCT (PREDNISOLONE/CINCHOCAINE) OINTMENT – 1 TUBE in Kenya can range from Ksh 1,500 to Ksh 2,500.

Note: Prices for medications like Scheriproct Ointment can vary between different pharmacies and online retailers in Kenya. Factors include supplier, specific retail pricing strategies, tube size, and any applicable taxes. Always check with specific vendors for the most current pricing.

Conclusion

SCHERIPROCT OINTMENT, containing Prednisolone Caproate and Cinchocaine Hydrochloride, provides a highly effective solution in Kenya for the rapid relief of pain, itching, swelling, and discomfort associated with common anorectal conditions like haemorrhoids, proctitis, pruritus ani, and mild anal fissures. Its dual action, combining an anti-inflammatory corticosteroid with a local anesthetic, addresses both the underlying inflammation and immediate symptomatic distress. While available without a prescription, its use requires adherence to a physician’s guidance and strict observance of the recommended short-term treatment duration (typically 5-7 days) to minimize potential side effects such as skin thinning or systemic absorption. Proper hygiene and application technique are also crucial for optimal results and safety.